Crossmark

Renal-clearable and tumor-retained nanodots overcoming metabolic reprogramming to boost mitochondrial-targeted photodynamic therapy in triple-negative breast cancer

Crossref DOI link: https://doi.org/10.1186/s12951-025-03264-7

Published Online: 2025-03-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Yao, Defan

Wang, Yanshu

Dong, Xue

Chen, Yanhong

Ji, Ding-Kun

Zou, Rongfeng

Huang, Yuelin

Huang, Weixi

Wang, Dengbin
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (82071870, 92159203, 82471976, 82472039)

Sponsored Program of Shanghai Science and Technology Committee (24TS1415300)
License Information

Text and Data Mining valid from 2025-03-10

Version of Record valid from 2025-03-10
More Information

Article History

Received: 3 December 2024

Accepted: 20 February 2025

First Online: 10 March 2025

Declarations

:

: The ethical review board of the XinHua Hospital Affiliated to Shanghai JiaoTong University School of Medicine, China, approved the experiment protocol and strictly followed its guidelines (Ethical approval number: XHEC-F-2023-014).

: The authors affirm that human research participant has provided informed consent for publication of human face. Signed participant publication approval was obtained from the participate.

: All authors read and agreed to submit the manuscript.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below